Royalty Pharma plc - Class A (RPRX) share price
Royalty Pharma plc - Class A (NASDAQ:RPRX) last traded at $67.3, down 0.40% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $38.70B and a 52-week range of $37.31 to $69.77.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $67.3 |
| 1-day move | -0.40% |
| 52-week range | $37.31 - $69.77 |
| Market cap | $38.70B |
| From 52-week high | -3.50% |
| Volume vs average | 1.6x |
| Falling Shares risk score | 7/100 (LOW) |
| Country | United States |
Frequently asked questions
Why is Royalty Pharma plc - Class A falling today?
Royalty Pharma plc - Class A (NASDAQ:RPRX) is down 0.40% at its latest quote and trades 3.5% below its 52-week high, on volume 1.6x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Royalty Pharma plc - Class A share price today?
Royalty Pharma plc - Class A (NASDAQ:RPRX) last traded at $67.3, a -0.40% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Royalty Pharma plc - Class A?
Royalty Pharma plc - Class A's 52-week low is $37.31 and its 52-week high is $69.77; the shares trade 3.5% below the high.
What is the market cap of Royalty Pharma plc - Class A?
Royalty Pharma plc - Class A has a market capitalisation of about $38.70B at the latest price.
What are the risks of investing in Royalty Pharma plc - Class A?
Falling Shares Intelligence rates Royalty Pharma plc - Class A 7/100 (LOW) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com